[COVID-19, drugs and hospital pharmacy].

Observation, interpretation, actions for improvement, questioning are all terms that echo the situation of caregivers since the outbreak of the COVID-19 epidemic in France at the beginning of 2020. All those involved in the healthcare chain have had to cope with the influx of patients and to show that they are capable of seeing their practices evolve on a daily basis. What was recommended a few weeks earlier could quickly become obsolete.

[Management of flows and supply shortages of health products in hospitals during the COVID-19 crisis].

The hospital pharmacy is a medico-technical department within the hospital which has been significantly affected by the COVID-19 crisis. It has been a crucial element in the supply and flow management of medicines and medical devices. The shortage of medicines, and in particular of five molecules essential for the treatment of COVID-19 patients, has resulted in stocks being managed on a national level in order to address these new and unknown challenges.

[Physicochemical incompatibilities of injectable drugs].

The physicochemical interactions of injectable drugs administered through a Y-site injection port are little known phenomena, poorly documented but very frequent. Physicochemical incompatibility is defined as a chemical reaction between two injectable drugs which come into contact with each other. This chemical reaction may be visible on a macroscopic level or completely invisible.